China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...
Supported Releases: These releases have been certified by Bloomberg’s Enterprise Products team for use by Bloomberg customers. Experimental Releases: These releases have not yet been certified for use ...
SINGAPORE, SINGAPORE, SINGAPORE, April 3, 2026 /EINPresswire.com/ — The first quarter of 2026 has been a wake-up call for the AI industry. In just two weeks in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results